Unique reagent access Kerafast provides a marketplace for unique lab-made reagents not widely available elsewhere, presenting a clear opportunity to pitch to research teams seeking rare cell lines, antibodies, and small molecules.

Royalty-backed model The platform handles selling and shipping while returning generous royalties to providing labs, which can be highlighted to potential institutional partners as a value proposition for funding ongoing research projects.

Global collaboration With researchers from over 170 institutions already using the platform, there is a strong case to expand outreach to similar universities, hospitals, and biotech labs seeking accessible, specialty reagents.

Antibody ecosystem As part of Absolute Biotech, Kerafast sits within a broader antibody reagents and services portfolio, enabling cross-sell opportunities to customers purchasing antibodies, recombinant tools, or related services.

Strategic partnerships Recent mergers and acquisitions in the ecosystem (Absolute Antibody, LSBio) indicate a market consolidation; approach is to propose co-marketing, bundled offerings, or channel partnerships to reach larger buyer bases.